Fortress Biotech, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Fortress Biotech, Inc. (FBIO) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $20.55 per share as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2025-11-14
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $20.55.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $20.55.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $20.55.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $20.55.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2025-09-30 | $20.55 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $20.55 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $20.55 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $20.55 10-K · filed 2025-03-31 | |
| 2024-09-30 | $20.55 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $20.55 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $20.55 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $20.55 10-K · filed 2024-03-28 | |
| 2023-09-30 | $61.70 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $4.11 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $4.11 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $4.34 10-K · filed 2023-03-31 | |
| 2022-09-30 | $4.34 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $4.44 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $4.44 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $5.04 10-K · filed 2022-03-28 | |
| 2021-09-30 | $5.04 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $4.54 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $4.54 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $4.54 10-K · filed 2020-03-16 | |
| 2019-09-30 | $4.60 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $4.60 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $3.75 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $3.75 10-K · filed 2019-03-18 | |
| 2018-09-30 | $3.75 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $3.75 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $3.75 10-Q · filed 2018-05-10 | |
| 2017-09-30 | $3.75 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $3.75 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $3.71 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $3.78 10-K · filed 2018-03-16 | $3.71 10-K · filed 2017-03-16 |
| 2016-09-30 | $3.77 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $3.77 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $3.75 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $3.69 10-K · filed 2016-03-15 | |
| 2014-12-31 | $4.33 10-K · filed 2015-03-16 | |
| 2014-09-30 | $4.40 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $4.42 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $4.24 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $3.75 10-K · filed 2014-03-14 | |
| 2013-09-30 | $3.95 10-Q · filed 2013-11-01 | |
| 2013-06-30 | $2.84 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $2.75 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $1.95 10-K · filed 2013-03-18 | |
| 2012-09-30 | $1.96 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $1.68 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |